With deep-rooted experience across oncology, HIV, endocrinology, and neurology therapeutics, Eirgen work with partners to bring critical therapies to life - safely, efficiently, and at scale. We specialize in the development and manufacture of oral solid dose formulations, including immediate-release, extended-release, and highly potent products. Our advanced capabilities in HPAPI handling, and high-volume manufacturing are tailored to both clinical and commercial supply. Every product we deliver aligns with global regulatory standards, including those of the EMA, FDA, and HPRA, ensuring that patients worldwide receive the therapies they depend on.